GEN Exclusives

More »

GEN News Highlights

Back to Item »

Teva Selects Champions' Tumorgraft Platform to Evaluate Anticancer Candidate

Firm claims technology can more accurately predict drug activity in multiple cancers than xenograft models.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Climate Change

How would you describe the researchers response to the 2°C global temperature target?

More »